Tag: biopharmaceutical third party logistics market trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Biopharmaceutical Third-Party Logistics Market During 2026–2030?

The biophotonics market has experienced swift expansion in its size over recent years. It is projected to increase from $92.07 billion in 2025 to $103.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. This historical market expansion is primarily attributed to advancements in optical sensor technologies, augmented funding for life sciences research, the broadening scope of biomedical imaging applications, the rising adoption of photonic tools in diagnostics, and growth in academic and clinical research.

The biophotonics market is set to experience significant expansion in the next few years. It is forecast to attain a value of $166.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. This projected growth stems from several factors, including the increasing demand for precision diagnostics, the expansion of personalized medicine applications, the rising integration of AI in optical imaging, the growing use of biophotonics in minimally invasive therapies, and the increasing adoption of point-of-care diagnostic devices. Key developments anticipated during this period involve the increasing use of optical imaging in diagnostics, the rising adoption of non-invasive light-based therapies, the growing integration of biophotonics in medical devices, the expansion of high-resolution microscopy techniques, and an enhanced focus on real-time biological monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12616&type=smp

What Major Growth Factors Are Impacting The Biopharmaceutical Third-Party Logistics Market?

The increasing demand for minimally invasive surgeries is expected to drive the expansion of the biophotonics market in the coming years. Optical engineering and imaging technologies have become vital for minimally invasive procedures, allowing for real-time visualization of tissue manipulation in remote internal locations. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based non-profit professional society, reported that the overall surgical and non-surgical procedures saw an increase of 3.4% in 2023, totaling 34.9 million. Therefore, the continuously rising number of minimally invasive surgeries performed globally each year is contributing to enhanced revenues within the biophotonics market.

Which Segment-Based Categories Are Covered In The Biopharmaceutical Third-Party Logistics Market?

The biopharmaceutical third-party logistics market covered in this report is segmented –

1) By Supply Chain: Cold Chain, Non-Cold Chain

2) By Service: Transportation, Warehousing And Storage, Other Services

3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging

2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

Which Trends Are Influencing The Expansion Of The Biopharmaceutical Third-Party Logistics Market?

Major companies active in the biophotonics market are concentrating on developing innovative products such as bronchoscopes for advanced medical procedures. Bronchoscopes are medical instruments utilized for examining the interior of the respiratory system. For instance, in September 2025, Olympus Corporation, a Japan‑based manufacturer of precision optics and medical devices, launched the BF‑UCP190F, a new endobronchial ultrasound (EBUS) bronchoscope tailored for lung lesion biopsy and advanced diagnostic applications. The device features a slender 5.9 mm outer diameter and 170° upward angulation, which permits physicians to navigate deep into the peribronchial region and enhance access to segmental and subsegmental airways. This launch strengthens Olympus’ biophotonics portfolio by merging optical imaging with real-time ultrasound guidance, addressing the escalating demand for minimally invasive lung sampling and improving diagnostic accuracy in thoracic oncology.

Who Are The Prominent Players Across The Biopharmaceutical Third-Party Logistics Market?

Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics

Access The Complete Biopharmaceutical Third-Party Logistics Market Report:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Which Region Stands As The Largest Contributor To The Biopharmaceutical Third-Party Logistics Market?

North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biopharmaceutical Third-Party Logistics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12616&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Third-Party Logistics Market 2026, By The Business Research Company

Biopharmaceutical Third Party Logistics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Pharmaceutical Logistics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Third Party Logistics 3Pl Market 2026

https://www.thebusinessresearchcompany.com/report/third-party-logistics-3pl-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Cranial Fixation System Market From 2026 To 2030?

The cranial fixation system market has experienced significant expansion in its size over recent years. Projections indicate it will expand from $1.62 billion in 2025 to $1.74 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. Historically, this expansion has been driven by factors such as an increase in traumatic brain injuries, a rise in neurosurgical procedures, the dependence on metallic implants, the prevalence of hospital-based surgical care, and the necessity for long-term cranial stability.

The cranial fixation system market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $2.33 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.5%. This expansion over the forecast period stems from factors such as progress in implant materials, an increase in neurosurgical facilities, escalating accident rates, the need for personalized implants, and better surgical results. Key developments expected during this timeframe encompass the growing embrace of biocompatible substances, the development of tailor-made cranial implants, broader application in trauma and neurosurgical procedures, the proliferation of absorbable fixation apparatus, and enhanced surgical exactness and stability.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cranial-fixation-system-global-market-report

What Significant Factors Are Influencing The Cranial Fixation System Market Expansion?

The increasing occurrence of traumatic brain injuries (TBI) is projected to stimulate the expansion of the cranial fixation system market moving forward. These injuries, known as traumatic brain injuries (TBI), involve damage to the brain resulting from an external force like a blow or sudden impact to the head. The growing prevalence of traumatic brain injuries (TBI) stems from a higher frequency of road traffic accidents, injuries linked to sports, senior falls, and trauma experienced in military combat. The cranial Fixation System functions by stabilizing skull fractures and holding bone fragments securely, thereby facilitating effective healing and minimizing complications for individuals suffering from traumatic brain injuries. To illustrate, data from April 2024, provided by the American Association of Neurological Surgeons (AANS), a US-based nonprofit neurosurgical association, indicated that in 2023, more than 21% of all traumatic brain injuries among American children and adolescents were due to sports and recreational pursuits. Annually, the United States experiences an estimated 1.7 to 3.8 million traumatic brain injuries. Consequently, the increased occurrence of traumatic brain injuries (TBI) is a key factor propelling the expansion of the cranial fixation system market.

Which Segment Classifications Are Used In The Cranial Fixation System Market Segment Analysis?

The cranial fixation system market covered in this report is segmented –

1) By Product Type: Implants, Mesh, Plates And Screws, Other Product Types

2) By Indications: Brain Aneurysm, Brain Cancer, Hydrocephalous, Other Indications

3) By Absorbability: Non Absorbable, Absorbable

4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Implants: Cranial Implants, Biocompatible Implants, Custom Implants

2) By Mesh: Titanium Mesh, Polymer Mesh, PEEK Mesh

3) By Plates and Screws: Titanium Plates and Screws, Stainless Steel Plates and Screws, Absorbable Plates and Screws

4) By Other Product Types: Cranial Staplers, Cranial Drills, Cranial Fixation Accessories

What Trends Are Affecting The Direction Of The Cranial Fixation System Market?

Leading companies engaged in the cranial fixation system market are prioritizing the development of innovative solutions, including advanced skull stabilization devices, to enhance the precision and safety of neurosurgical interventions. Skull stabilization devices are specialized medical tools specifically engineered to securely hold and stabilize the skull throughout neurosurgical procedures. As an illustration, in July 2023, Stryker Corporation, a US-based medication firm, unveiled the Q guidance system featuring cranial guidance software. The Q guidance system, along with its cranial guidance software, improves cranial surgeries by offering exact navigation and sophisticated imaging functionalities, thus refining surgical planning and accuracy. Its user-friendly interface and high-speed operation streamline professional workflows, ultimately contributing to superior patient outcomes.

Which Firms Are Contributing To The Cranial Fixation System Market Ecosystem?

Major companies operating in the cranial fixation system market are Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corporation, 3D Systems Corporation, KLS Martin LP, Aesculap AG, Fin-ceramica Faenza SpA, Medyssey Co. Ltd, Evonos GmbH & Co KG, DePuy Synthes Companies of Johnson & Johnson, Bioplate Inc, Jeil Medical Corporation, Adeor Medical AG, NEOS Surgery SL, Osteopore International Pty Ltd, Xilloc Medical BV, OsteoMed LP, Medartis AG, Matrix Surgical USA, Cavendish Implants, CranioTech, Vitalys Surgical

Get The Full Cranial Fixation System Market Report:

https://www.thebusinessresearchcompany.com/report/cranial-fixation-system-global-market-report

Which Region Has The Greatest Market Share In The Cranial Fixation System Market?

North America was the largest region in the cranial fixation system market in 2025. The regions covered in the cranial fixation system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cranial Fixation System Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cranial-fixation-system-global-market-report

Browse Through More Reports Similar to the Global Cranial Fixation System Market 2026, By The Business Research Company

Skull Clamp Market Report 2026

https://www.thebusinessresearchcompany.com/report/skull-clamp-global-market-report

Cranial Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cranial-implants-global-market-report

Craniomaxillofacial Cmf Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/craniomaxillofacial-cmf-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Biopharmaceutical Third-Party Logistics Market From 2026 To 2030?

Recent years have witnessed substantial growth in the biopharmaceutical third-party logistics market. It is projected to expand from $150.5 billion in 2025 to $161.71 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historic growth has been fueled by an increase in biologics and vaccine production, the rising trend of pharmaceutical companies outsourcing logistics services, the expansion of global biopharmaceutical supply chains, more stringent regulatory requirements for drug transportation, and the limited in-house logistics capabilities of biopharma firms.

The biopharmaceutical third-party logistics market is projected to experience substantial expansion in the coming years, reaching a size of $221.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period is driven by factors such as the surging demand for personalized medicines, the broadening distribution of cell and gene therapies, increased investments in intelligent logistics platforms, a heightened emphasis on comprehensive supply chain transparency, and the rise in international biopharmaceutical commerce. Key developments anticipated within this timeframe involve the greater integration of sophisticated cold chain logistics solutions, an escalating need for transportation services that monitor temperature, wider deployment of real-time shipment tracking systems, the growth of specialized biopharma warehousing facilities, and a sharpened focus on logistics operations adhering to regulations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

What Key Drivers Are Fueling The Growth Of The Biopharmaceutical Third-Party Logistics Market?

The increasing inclination towards outsourcing logistics is anticipated to fuel expansion in the biopharmaceutical third-party logistics market. This practice, outsourcing logistics, entails contracting an external entity to manage either all or a segment of a firm’s logistical operations. Within biopharmaceutical third-party logistics, outsourcing logistics finds application in delegating cryogenic supply chain management to specialized logistics partners. As an illustration, data from February 2024, provided by the Bureau of Transportation Statistics, a US-based division of the Department of Transportation (DOT), indicated that for-hire freight shipments saw an increase of 1.8% in December 2023 when juxtaposed with December 2022, concurrently, the Freight Transportation Services Index climbed from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the expanding practice of outsourcing logistics is projected to invigorate the expansion of the biopharmaceutical third-party logistics market.

Which Segment Classifications Are Used In The Biopharmaceutical Third-Party Logistics Market Segment Analysis?

The biopharmaceutical third-party logistics market covered in this report is segmented –

1) By Supply Chain: Cold Chain, Non-Cold Chain

2) By Service: Transportation, Warehousing And Storage, Other Services

3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging

2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

What Trends Are Influencing The Biopharmaceutical Third-Party Logistics Market?

Leading firms within the biopharmaceutical third-party logistics market are prioritizing strategic initiatives like business expansion in life sciences and healthcare logistics to improve logistical prowess concerning pharmaceutical and healthcare products, thereby ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics involves the calculated development by logistics providers to boost their proficiency in moving and overseeing medical products, which is vital for guaranteeing prompt arrival and preserving the condition of temperature-sensitive items essential for patient care. As an illustration, in May 2025, DHL Group, a Germany-based logistics company, unveiled its revamped Life Sciences & Healthcare (LSH) campus in Florstadt, Germany. This modern site features ultra cold storage zones (down to –70°C), real-time visibility systems, and GDP certified infrastructure, facilitating the safe management of temperature-sensitive biopharmaceuticals, such as mRNA vaccines, clinical trial materials, and advanced therapies.

Which Firms Are Contributing To The Biopharmaceutical Third-Party Logistics Market Ecosystem?

Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics

Get The Full Biopharmaceutical Third-Party Logistics Market Report:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Which Region Accounts For The Largest Portion Of The Biopharmaceutical Third-Party Logistics Market?

North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biopharmaceutical Third-Party Logistics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Browse Through More Reports Similar to the Global Biopharmaceutical Third-Party Logistics Market 2026, By The Business Research Company

Third Party Logistics 3Pl Market 2026

https://www.thebusinessresearchcompany.com/report/third-party-logistics-3pl-market

Biopharmaceutical Third Party Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Pharmaceutical Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Biopharmaceutical Third-Party Logistics Market From 2026 To 2030?

Recent years have witnessed substantial growth in the biopharmaceutical third-party logistics market. It is projected to expand from $150.5 billion in 2025 to $161.71 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historic growth has been fueled by an increase in biologics and vaccine production, the rising trend of pharmaceutical companies outsourcing logistics services, the expansion of global biopharmaceutical supply chains, more stringent regulatory requirements for drug transportation, and the limited in-house logistics capabilities of biopharma firms.

The biopharmaceutical third-party logistics market is projected to experience substantial expansion in the coming years, reaching a size of $221.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period is driven by factors such as the surging demand for personalized medicines, the broadening distribution of cell and gene therapies, increased investments in intelligent logistics platforms, a heightened emphasis on comprehensive supply chain transparency, and the rise in international biopharmaceutical commerce. Key developments anticipated within this timeframe involve the greater integration of sophisticated cold chain logistics solutions, an escalating need for transportation services that monitor temperature, wider deployment of real-time shipment tracking systems, the growth of specialized biopharma warehousing facilities, and a sharpened focus on logistics operations adhering to regulations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

What Key Drivers Are Fueling The Growth Of The Biopharmaceutical Third-Party Logistics Market?

The increasing inclination towards outsourcing logistics is anticipated to fuel expansion in the biopharmaceutical third-party logistics market. This practice, outsourcing logistics, entails contracting an external entity to manage either all or a segment of a firm’s logistical operations. Within biopharmaceutical third-party logistics, outsourcing logistics finds application in delegating cryogenic supply chain management to specialized logistics partners. As an illustration, data from February 2024, provided by the Bureau of Transportation Statistics, a US-based division of the Department of Transportation (DOT), indicated that for-hire freight shipments saw an increase of 1.8% in December 2023 when juxtaposed with December 2022, concurrently, the Freight Transportation Services Index climbed from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the expanding practice of outsourcing logistics is projected to invigorate the expansion of the biopharmaceutical third-party logistics market.

Which Segment Classifications Are Used In The Biopharmaceutical Third-Party Logistics Market Segment Analysis?

The biopharmaceutical third-party logistics market covered in this report is segmented –

1) By Supply Chain: Cold Chain, Non-Cold Chain

2) By Service: Transportation, Warehousing And Storage, Other Services

3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging

2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

What Trends Are Influencing The Biopharmaceutical Third-Party Logistics Market?

Leading firms within the biopharmaceutical third-party logistics market are prioritizing strategic initiatives like business expansion in life sciences and healthcare logistics to improve logistical prowess concerning pharmaceutical and healthcare products, thereby ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics involves the calculated development by logistics providers to boost their proficiency in moving and overseeing medical products, which is vital for guaranteeing prompt arrival and preserving the condition of temperature-sensitive items essential for patient care. As an illustration, in May 2025, DHL Group, a Germany-based logistics company, unveiled its revamped Life Sciences & Healthcare (LSH) campus in Florstadt, Germany. This modern site features ultra cold storage zones (down to –70°C), real-time visibility systems, and GDP certified infrastructure, facilitating the safe management of temperature-sensitive biopharmaceuticals, such as mRNA vaccines, clinical trial materials, and advanced therapies.

Which Firms Are Contributing To The Biopharmaceutical Third-Party Logistics Market Ecosystem?

Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics

Get The Full Biopharmaceutical Third-Party Logistics Market Report:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Which Region Accounts For The Largest Portion Of The Biopharmaceutical Third-Party Logistics Market?

North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biopharmaceutical Third-Party Logistics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Browse Through More Reports Similar to the Global Biopharmaceutical Third-Party Logistics Market 2026, By The Business Research Company

Third Party Logistics 3Pl Market 2026

https://www.thebusinessresearchcompany.com/report/third-party-logistics-3pl-market

Biopharmaceutical Third Party Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Pharmaceutical Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Biopharmaceutical Third-Party Logistics Market Over The Period 2026–2030?

The biopharmaceutical third-party logistics market size has demonstrated substantial growth recently. It is projected to expand from $150.5 billion in 2025 to $161.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. This historical growth can be linked to factors such as increased production of biologics and vaccines, the growing trend of pharmaceutical companies outsourcing their logistics services, the expansion of global biopharmaceutical supply chains, stricter regulatory demands for drug transportation, and the constrained in-house logistics capabilities among biopharma firms.

The biopharmaceutical third-party logistics market is projected to experience substantial expansion in the coming years, reaching $221.15 billion in 2030 with a compound annual growth rate (CAGR) of 8.1%. This anticipated growth is driven by factors such as a rise in demand for personalized medicines, the broadening distribution of cell and gene therapies, increased investments in smart logistics platforms, a heightened emphasis on comprehensive supply chain visibility, and the growing volume of international biopharmaceutical trade. Key trends emerging during this period encompass the greater adoption of sophisticated cold chain logistics solutions, an uptick in the need for temperature-controlled transportation services, the expanding utilization of real-time shipment tracking platforms, the development of specialized biopharma warehousing infrastructure, and a reinforced commitment to regulatory-compliant logistics practices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12616&type=smp

What Underlying Factors Are Accelerating The Growth Of The Biopharmaceutical Third-Party Logistics Market?

The increasing practice of logistics outsourcing is anticipated to fuel expansion within the biopharmaceutical third-party logistics market. This process entails entrusting an external entity with managing either the entirety or specific segments of a firm’s logistical operations. Specifically, within biopharmaceutical third-party logistics, outsourcing logistics is utilized for delegating cryogenic supply chain management responsibilities to specialized logistics collaborators. As an illustration, data from February 2024, sourced from the Bureau of Transportation Statistics, a US Department of Transportation (DOT) agency, revealed that for-hire freight shipments experienced a 1.8% rise in December 2023 relative to December 2022. Concurrently, the Freight Transportation Services Index climbed from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the expanding trend of outsourcing logistics is projected to significantly boost the development of the biopharmaceutical third-party logistics market.

How Is The Biopharmaceutical Third-Party Logistics Market Divided Into Its Major Segments?

The biopharmaceutical third-party logistics market covered in this report is segmented –

1) By Supply Chain: Cold Chain, Non-Cold Chain

2) By Service: Transportation, Warehousing And Storage, Other Services

3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging

2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

Which Market Trends Are Creating New Opportunities In The Biopharmaceutical Third-Party Logistics Market?

Key companies within the biopharmaceutical third-party logistics market are concentrating on innovative strategies, including business expansion in life sciences and healthcare logistics, to strengthen their logistical capacity for pharmaceutical and healthcare products, thereby ensuring effective storage and distribution. This expansion in life sciences and healthcare logistics signifies the deliberate growth of logistics firms to enhance their abilities in transporting and managing medical items, a critical factor for guaranteeing timely delivery and preserving the integrity of temperature-sensitive products vital for patient care. As an illustration, in May 2025, DHL Group, a logistics company from Germany, unveiled the grand opening of its modernized Life Sciences & Healthcare (LSH) campus in Florstadt, Germany. The new facility incorporates ultra cold storage zones, capable of reaching –70°C, along with real-time visibility systems and GDP certified infrastructure, facilitating the secure handling of sensitive biopharmaceuticals such as mRNA vaccines, clinical trial materials, and advanced therapies.

Who Are The Prominent Organizations Shaping The Biopharmaceutical Third-Party Logistics Market?

Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics

Read the full biopharmaceutical third-party logistics market report here:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Which Region Is Projected To Dominate The Biopharmaceutical Third-Party Logistics Market During The Forecast Period?

North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biopharmaceutical Third-Party Logistics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12616&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Third-Party Logistics Market 2026, By The Business Research Company

Biopharmaceutical Third Party Logistics Global Market Report

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Pharmaceutical Logistics Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Third Party Logistics 3Pl Market

https://www.thebusinessresearchcompany.com/report/third-party-logistics-3pl-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model